INFLUENCE OF INTRACISTERNAL INJECTION OF SOMATOSTATIN ANALOG RECEPTOR SUBTYPE-2, SUBTYPE-3 AND SUBTYPE-5 ON GASTRIC-ACID SECRETION IN CONSCIOUS RATS

被引:10
|
作者
MARTINEZ, V
COY, DH
TACHE, Y
机构
[1] UNIV CALIF LOS ANGELES, VET ADM MED CTR W,BRAIN RES INST,CURE, GASTROENTER CTR, LOS ANGELES, CA 90073 USA
[2] TULANE UNIV, MED CTR, DEPT MED, PEPTIDE RES LABS, NEW ORLEANS, LA 70112 USA
关键词
SOMATOSTATIN ANALOGS; BRAIN-STEM; GASTRIC ACID SECRETION; RAT;
D O I
10.1016/0304-3940(95)11286-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Somatostatin (SST) and its analogs injected into the CSF induce different gastric acid response patterns. Five SST receptors have been characterized (SSTR-1 to -5), We studied the influence of selective SSTR-2, -3 and -5 ligands on basal gastric acid secretion after intracisternal (i,c,) injection in conscious rats equipped with chronic gastric and i.c. cannulae. Compared with pre-injection level, the SSTR-3 agonist, BIM-23056 (1 mu g) increased acid secretion by 274 +/- 43% while the SSTR-2 agonist, DC 32-87 (1 mu g) inhibited acid secretion by 50.7 +/- 13.3%. SST-14 (1 mu g), the SSTR-5 agonist, BIM-23052, (0.5-1 mu g), SSTR-3 (0.5 mu g) and -2 (0.5 mu g) or vehicle injected i.c. did not modify basal acid secretion. These results show that the activation of brainstem SSTR-3 receptors stimulate and SSTR-2 inhibit basal gastric acid secretion in conscious rats with chronic gastric fistulae.
引用
收藏
页码:79 / 82
页数:4
相关论文
共 42 条
  • [21] Intracisternal injection of somatostatin analog SMS 201-995-induced inhibition of gastric acid secretion involves central opioid pathways in rats.
    Coskun, T
    Martinez, V
    Tache, Y
    GASTROENTEROLOGY, 1996, 110 (04) : A1065 - A1065
  • [22] A new 68Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting
    Rosalba Mansi
    Karim Abid
    Guillaume P. Nicolas
    Luigi Del Pozzo
    Eric Grouzmann
    Melpomeni Fani
    EJNMMI Research, 10
  • [23] A new 68Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting
    Mansi, Rosalba
    Abid, Karim
    Nicolas, Guillaume P.
    Del Pozzo, Luigi
    Grouzmann, Eric
    Fani, Melpomeni
    EJNMMI RESEARCH, 2020, 10 (01)
  • [24] Somatostatin receptor subtype-2 and -3-selective agonists inhibit insulin secretion from INS-1 cells through modulation of the R-type Ca2+channel activity
    Mergler, S.
    Singh, V
    Zacharias, S.
    Wiedenmann, B.
    Ploeckinger, U.
    Strowski, M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 : S32 - S33
  • [25] Discovery of Dimethyl Shikonin Oxime 5a, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Type 2 Diabetes Mellitus
    Wu, Lehao
    Cui, Jiahua
    Zhao, Chunxiao
    Wang, Zeyuan
    Lu, Jihong
    Li, Shaoshun
    Jia, Jinping
    Xiao, Hua
    Zhang, Yan
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (12) : 8011 - 8029
  • [26] Synthesis and SAR of heterocyclic carboxylic acid isosteres based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity
    Hadden, Mark
    Goodman, Allan
    Guo, Cheng
    Guzzo, Peter R.
    Henderson, Alan J.
    Pattamana, Kevin
    Ruenz, Megan
    Sargent, Bruce J.
    Swenson, Brian
    Yet, Larry
    Liu, Jian
    He, Shuwen
    Sebhat, Iyassu K.
    Lin, Linus S.
    Tamvakopoulos, Constantin
    Peng, Qianping
    Kan, Yanqing
    Palyha, Oksana
    Kelly, Theresa M.
    Guan, Xiao-Ming
    Metzger, Joseph M.
    Reitman, Marc L.
    Nargund, Ravi P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (09) : 2912 - 2915
  • [27] GLP-1 Secretion Is Increased upon Blockade of the Somatostatin Receptor Subtype 2 and 5 Resulting in GLP-1 Receptor-Mediated Lowering of Blood Glucose in Mice
    Jepsen, Sara L.
    Albrechtsen, Nicolai J. Wewer
    Pedersen, Jens
    Engelstoft, Maja S.
    Deacon, Carolyn F.
    Holst, Jens J.
    DIABETES, 2018, 67
  • [28] New potent somatostatin receptor 2 antagonist inhibits SRIF and SRIF-mediated effects on pentagastrin-stimulated gastric acid secretion in conscious rats.
    Rossowski, WJ
    Cheng, BL
    Coy, DH
    GASTROENTEROLOGY, 1998, 114 (04) : A1175 - A1175
  • [29] In vivo characterization and dynamic receptor occupancy imaging of TPA023B, an α2/α3/α5 subtype selective γ-aminobutyric acid-A partial agonist
    Van Laere, Koen
    Bormans, Guy
    Sanabria-Bohorquez, Sandra M.
    de Groot, Tjibbe
    Dupont, Patrick
    De Lepeleire, Inge
    de Hoon, Jan
    Mortelmans, Luc
    Hargreaves, Richard J.
    Atack, John R.
    Burns, H. Donald
    BIOLOGICAL PSYCHIATRY, 2008, 64 (02) : 153 - 161
  • [30] SYNTHESIS OF [F-18] LABELED 5-HT SUBTYPE-3 RECEPTOR ANTAGONIST - 4-(4-[F18]FLUOROPHENYL)-2-[4(5)-METHYL-5(4)-IMIDAZOLYLMETHYL]THIAZOLE
    HWANG, DR
    BANKS, W
    NAGEL, AA
    ROSEN, T
    MANTIL, J
    JOURNAL OF NUCLEAR MEDICINE, 1991, 32 (09) : 1841 - 1841